These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3584523

  • 1. Initial severity and diagnosis influence the relationship of tricyclic plasma levels to response: a statistical review.
    Boyer WF, Lake CR.
    J Clin Psychopharmacol; 1987 Apr; 7(2):67-71. PubMed ID: 3584523
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC, Huey LY, Janowsky DS.
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [Abstract] [Full Text] [Related]

  • 3. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB.
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [Abstract] [Full Text] [Related]

  • 4. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE.
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [Abstract] [Full Text] [Related]

  • 5. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ, Zeilmann C, Arndt S.
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [Abstract] [Full Text] [Related]

  • 6. Drug level monitoring in psychopharmacology: usefulness and clinical problems, with special reference to tricyclic antidepressants.
    Gram LF, Pedersen OL, Kristensen CB, Bjerre M, Kragh-Sørensen P.
    Ther Drug Monit; 1982 Aug; 4(1):17-25. PubMed ID: 7041335
    [Abstract] [Full Text] [Related]

  • 7. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
    Franke L, Schewe HJ, Uebelhack R, Müller-Oerlinghausen B.
    Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
    [Abstract] [Full Text] [Related]

  • 8. Plasma monitoring of tricyclic antidepressants: defining the therapeutic range for imipramine in depressed children.
    Preskorn SH, Weller E, Hughes C, Weller R.
    Clin Neuropharmacol; 1986 Jul; 9 Suppl 4():265-7. PubMed ID: 3552217
    [No Abstract] [Full Text] [Related]

  • 9. Tricyclic antidepressants: a simplified approach for the routine clinical monitoring of parent drug and metabolites in plasma using HPLC.
    Dixon R, Marin D.
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):537-45. PubMed ID: 7330455
    [Abstract] [Full Text] [Related]

  • 10. Plasma level monitoring of antidepressants: theoretical basis and clinical application.
    Gram LF, Kragh-Sørensen P, Kristensen CB, Møller M, Pedersen OL, Thayssen P.
    Adv Biochem Psychopharmacol; 1984 Sep; 39():399-411. PubMed ID: 6380231
    [Abstract] [Full Text] [Related]

  • 11. Tricyclic antidepressant plasma levels: the state of the art and clinical prospects.
    Razavi D, Mendlewicz J.
    Neuropsychobiology; 1982 Sep; 8(2):73-85. PubMed ID: 7070646
    [Abstract] [Full Text] [Related]

  • 12. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N, Siobud-Dorocant E, Even C, Slama F, Dardennes R.
    Encephale; 2001 Sep; 27(4):373-6. PubMed ID: 11686060
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant and antipsychotic plasma levels.
    Boyer WF, Friedel RO.
    Psychiatr Clin North Am; 1984 Sep; 7(3):601-10. PubMed ID: 6148744
    [Abstract] [Full Text] [Related]

  • 14. [Drug therapy of depression: benefits and limits of blood levels of tricyclic antidepressants].
    Baumann P.
    Schweiz Med Wochenschr; 1981 Feb 14; 111(7):228-39. PubMed ID: 7013064
    [Abstract] [Full Text] [Related]

  • 15. [Grapefruit juice as a contraindication? An approach in psychiatry].
    Vandel P, Regina W, Reix I, Vandel S, Sechter D, Bizouard P.
    Encephale; 1999 Feb 14; 25(1):67-71. PubMed ID: 10205736
    [Abstract] [Full Text] [Related]

  • 16. Monitoring tricyclic antidepressant plasma concentrations.
    Hollister LE.
    JAMA; 1979 Jun 08; 241(23):2530-3. PubMed ID: 439339
    [Abstract] [Full Text] [Related]

  • 17. Relationship between age and tricyclic antidepressant plasma levels.
    Nies A, Robinson DS, Friedman MJ, Green R, Cooper TB, Ravaris CL, Ives JO.
    Am J Psychiatry; 1977 Jul 08; 134(7):790-3. PubMed ID: 869057
    [Abstract] [Full Text] [Related]

  • 18. Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach.
    Preskorn SH.
    J Clin Psychiatry; 1986 Jan 08; 47(1 Suppl):24-30. PubMed ID: 2867088
    [Abstract] [Full Text] [Related]

  • 19. The role of plasma concentrations in the use of tricyclic antidepressant drugs.
    Levine RR.
    Prog Neuropsychopharmacol; 1979 Jan 08; 3(1-3):211-22. PubMed ID: 401340
    [Abstract] [Full Text] [Related]

  • 20. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.
    Rubin EH, Biggs JT, Preskorn SH.
    J Clin Psychiatry; 1985 Oct 08; 46(10):418-24. PubMed ID: 3900052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.